Integram Life Sciences 株式はQ1の損失と収益の減少で25%減少した. Integra LifeSciences' stock plunges 25% after Q1 loss and reduced profit forecasts.

Integra LifeSciencesは,昨年330万ドルから2530万ドルの Q1 純損失を報告した後,その株式はほぼ25%減って12.78ドルとなった. Integra LifeSciences saw its stock drop by nearly 25% to $12.78 after reporting a Q1 net loss of $25.3 million, up from $3.3 million last year. 収益が382.7百万ドルにわずかに増加したにもかかわらず,同社は関税の影響によりEPSの予測を調整した. Despite a slight revenue increase to $382.7 million, the company adjusted its EPS guidance due to tariff impacts. インテグラは2025年度の収益予測を見直したが,品質問題とキーエリアでの販売の遅れにより利益の期待が低下した. Integra reaffirmed its 2025 revenue forecast but reduced profit expectations due to quality issues and slower sales in key areas. 株式は不安定で、過去1年間で5%を超える動きが21つあった。 Shares have been volatile, with 21 moves over 5% in the past year.